VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $794,008 | -42.2% | 183,798 | -11.8% | 0.00% | – |
| Q2 2023 | $1,373,283 | +1007.5% | 208,389 | +1734.7% | 0.00% | – |
| Q2 2022 | $124,000 | -3.1% | 11,358 | 0.0% | 0.00% | – |
| Q1 2022 | $128,000 | -31.6% | 11,358 | -4.3% | 0.00% | – |
| Q4 2021 | $187,000 | -59.4% | 11,869 | -57.8% | 0.00% | – |
| Q4 2019 | $461,000 | -69.3% | 28,122 | -73.8% | 0.00% | – |
| Q1 2017 | $1,502,000 | -43.3% | 107,313 | -35.3% | 0.00% | -100.0% |
| Q4 2016 | $2,647,000 | +199.8% | 165,959 | +112.1% | 0.00% | – |
| Q3 2015 | $883,000 | -22.4% | 78,240 | -12.7% | 0.00% | – |
| Q2 2015 | $1,138,000 | +36.5% | 89,640 | 0.0% | 0.00% | – |
| Q1 2015 | $834,000 | -41.2% | 89,640 | -9.5% | 0.00% | – |
| Q4 2014 | $1,418,000 | +25.3% | 99,010 | -9.2% | 0.00% | – |
| Q3 2014 | $1,132,000 | -44.6% | 109,100 | -13.7% | 0.00% | -100.0% |
| Q2 2014 | $2,045,000 | -0.4% | 126,400 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,054,000 | – | 126,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |